WallStreetZenWallStreetZen

NASDAQ: KA
Kineta Inc Stock

$0.69-0.01 (-1.43%)
Updated Jul 19, 2024
KA Price
$0.69
Fair Value Price
N/A
Market Cap
$8.41M
52 Week Low
$0.33
52 Week High
$5.39
P/E
-0.46x
P/B
-1.31x
P/S
1.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.16M
Earnings
-$17.89M
Gross Margin
100%
Operating Margin
-339.66%
Profit Margin
-346.6%
Debt to Equity
-1.36
Operating Cash Flow
-$15M
Beta
0.86
Next Earnings
Aug 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

KA Overview

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

KA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KA is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
KA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 35 more KA due diligence checks available for Premium users.

Be the first to know about important KA news, forecast changes, insider trades & much more!

Valuation

KA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.46x
Industry
-18.27x
Market
29.62x

KA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.31x
Industry
6.22x

KA's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.2M
Profit Margin
0%
KA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
KA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.4M
Liabilities
$8.7M
Debt to equity
-1.36
KA's short-term liabilities ($8.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KA's short-term assets ($2.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.0M
Investing
$0.0
Financing
$1.0k
KA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

KA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
KA$8.41M-1.29%-0.46x-1.31x
ONVO$8.49M-3.90%-0.37x2.36x
ADXN$8.31M+1.12%-55.48x-5.39x
MTEM$8.82M-6.29%-1.21x1.50x
CLDI$8.96M+7.98%-0.26x-0.62x

Kineta Stock FAQ

What is Kineta's quote symbol?

(NASDAQ: KA) Kineta trades on the NASDAQ under the ticker symbol KA. Kineta stock quotes can also be displayed as NASDAQ: KA.

If you're new to stock investing, here's how to buy Kineta stock.

What is the 52 week high and low for Kineta (NASDAQ: KA)?

(NASDAQ: KA) Kineta's 52-week high was $5.39, and its 52-week low was $0.33. It is currently -87.27% from its 52-week high and 105.39% from its 52-week low.

How much is Kineta stock worth today?

(NASDAQ: KA) Kineta currently has 12,254,455 outstanding shares. With Kineta stock trading at $0.69 per share, the total value of Kineta stock (market capitalization) is $8.41M.

Kineta stock was originally listed at a price of $929.60 in Feb 11, 2016. If you had invested in Kineta stock at $929.60, your return over the last 8 years would have been -99.93%, for an annualized return of -59.4% (not including any dividends or dividend reinvestments).

How much is Kineta's stock price per share?

(NASDAQ: KA) Kineta stock price per share is $0.69 today (as of Jul 19, 2024).

What is Kineta's Market Cap?

(NASDAQ: KA) Kineta's market cap is $8.41M, as of Jul 21, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Kineta's market cap is calculated by multiplying KA's current stock price of $0.69 by KA's total outstanding shares of 12,254,455.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.